Followers | 114 |
Posts | 9221 |
Boards Moderated | 0 |
Alias Born | 05/15/2008 |
Tuesday, May 10, 2016 8:14:25 PM
“Our company has focused aggressively on two critical items, 1) the final phase of integration of Response Genetics, and 2) on developing new business contracts – both clinical and biopharma – with partners that will be essential to
http://www.cancergenetics.com/cancer-genetics-inc-announces-39-revenue-increase-and-provides-recent-company-highlights/
I'm holding a nice position here, but up until now, all on instinct.
Thinking of adding. Any thoughts?
Trackkwizzard...Telematic fanatic...tracking.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM